Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo khoa học: "Abnormal hCG levels in a patient with treated stage I seminoma: a diagnostic dilemma"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Abnormal hCG levels in a patient with treated stage I seminoma: a diagnostic dilemma | BioMed Central World Journal of Surgical Oncology Open Access Case report Abnormal hCG levels in a patient with treated stage I seminoma a diagnostic dilemma Noel J Aherne 1 Cormac A Small1 Gerard P McVey1 David A Fitzpatrick1 and John G Armstrong2 Address Department of Radiation Oncology St. Luke s Hospital Dublin Ireland and - Department of Radiation Oncology University College Dublin Dublin Ireland Email Noel J Aherne - noelaherne@eircom.net Cormac A Small - cormac.small@slh.ie Gerard P McVey - gerard.mcvey@slh.ie David A Fitzpatrick - dfitz97@gmail.com John G Armstrong - armstrongtravelling@gmail.com Corresponding author Published 25 June 2008 Received 27 February 2008 World Journal of Surgical Oncology 2008 6 68 doi 10.1186 1477-7819-6-68 Accepted 25 June 2008 This article is available from http www.wjso.cOm content 6 1 68 2008 Aherne et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background We report the case of a patient with treated Stage la seminoma who was found to have an elevated beta human chorionic gonadotrophin hCG on routine follow - up. This instigated restaging and could have lead to commencement of chemotherapy. Case presentation The patient was a bodybuilder and following a negative metastatic work -up admitted to injecting exogenous beta hCG. This was done to reduce withdrawal symptoms from androgen abuse. The patient remains well eight years post diagnosis. Conclusion This case highlights the need for surgical oncologists to conduct vigilant screening of young male patients with a history of testicular germ cell tumours and who may indulge in steroid abuse. Background Testicular cancer accounts for 1 of all male cancers 1 and while the incidence has doubled in the last twenty years the